HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print October 4, 2005

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0405223v1 78/6/1215    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rittner, H. L. Articles by Stein, C. Search for Related Content PubMed PubMed Citation Articles by Rittner, H. L. Articles by Stein, C.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0405223

Received for publication June 2, 2005.

Accepted for publication July 11, 2005.

Article

Leukocytes in the regulation of pain and analgesia

Klinik für Anästhesiologie und operative Intensivmedizin, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany

^@ To whom correspondence should be addressed. E-mail: heike.rittner{at}charite.de.

	Abstract

When tissue is destroyed or invaded by leukocytes in inflammation, numerous mediators are delivered by the circulation and/or liberated from resident and immigrated cells at the site. Proalgesic mediators include proinflammatory cytokines, chemokines, protons, nerve growth factor, and prostaglandins, which are produced by invading leukocytes or by resident cells. Less well known is that analgesic mediators, which counteract pain, are also produced in inflamed tissues. These include anti-inflammatory cytokines and opioid peptides. Interactions between leukocyte-derived opioid peptides and opioid receptors can lead to potent, clinically relevant inhibition of pain (analgesia). Opioid receptors are present on peripheral endings of sensory neurons. Opioid peptides are synthesized in circulating leukocytes, which migrate to inflamed tissues directed by chemokines and adhesion molecules. Under stressful conditions or in response to releasing agents (e.g., corticotropin-releasing factor, cytokines, noradrenaline), leukocytes can secrete opioids. They activate peripheral opioid receptors and produce analgesia by inhibiting the excitability of sensory nerves and/or the release of excitatory neuropeptides. This review presents discoveries that led to the concepts of pain generation by mediators secreted from leukocytes and of analgesia by immune-derived opioids.

Key Words: inflammation • neuropathy • hyperalgesia • cytokines • chemokines • opioid peptides

This article has been cited by other articles:

				S. Hagiwara, H. Iwasaka, A. Hasegawa, and T. Noguchi Pre-Irradiation of Blood by Gallium Aluminum Arsenide (830 nm) Low-Level Laser Enhances Peripheral Endogenous Opioid Analgesia in Rats Anesth. Analg., September 1, 2008; 107(3): 1058 - 1063. [Abstract] [Full Text] [PDF]

				O. Lian, J. Dahl, P. W. Ackermann, F. Frihagen, L. Engebretsen, and R. Bahr Pronociceptive and Antinociceptive Neuromediators in Patellar Tendinopathy Am. J. Sports Med., November 1, 2006; 34(11): 1801 - 1808. [Abstract] [Full Text] [PDF]

				S. D. Eicher, H. W. Cheng, A. D. Sorrells, and M. M. Schutz Short communication: behavioral and physiological indicators of sensitivity or chronic pain following tail docking. J Dairy Sci, August 1, 2006; 89(8): 3047 - 3051. [Abstract] [Full Text] [PDF]

				H. Shen, H. Sprott, A. Aeschlimann, R. E. Gay, B. A. Michel, S. Gay, and H. Sprott Analgesic action of acetaminophen in symptomatic osteoarthritis of the knee Rheumatology, June 1, 2006; 45(6): 765 - 770. [Abstract] [Full Text] [PDF]

				H. L. Rittner, S. A. Mousa, D. Labuz, K. Beschmann, M. Schafer, C. Stein, and A. Brack Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain J. Leukoc. Biol., May 1, 2006; 79(5): 1022 - 1032. [Abstract] [Full Text] [PDF]